TY - JOUR
T1 - Clinical, psychosocial, and demographic factors associated with health-related quality of life profiles of women with breast cancer in early phases of survivorship
AU - Graves, Kristi D.
AU - Fall-Dickson, Jane M.
AU - Reeve, Bryce B.
AU - Lin, Li
AU - Ahn, Jaeil
AU - Pan, Wei
AU - Potosky, Arnold L.
N1 - Publisher Copyright:
Copyright © 2025 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the International Psycho-Oncology Society.
PY - 2025/7/1
Y1 - 2025/7/1
N2 - Background: We aimed to identify health-related quality of life (HRQOL) profiles among breast cancer survivors and factors associated with each profile. Methods: Breast cancer survivors diagnosed 6–13 months earlier completed surveys assessing sociodemographic, clinical, and HRQOL variables (NIH PROMIS short forms). Using latent profile analysis (LPA), we grouped survivors into HRQOL profiles of PROMIS scores based on model fit and clinical interpretability. We used multinomial logistic regression models to determine clinical, psychosocial, and demographic factors associated with each HRQOL profile. Results: Among 1,638 breast cancer survivors, we identified four HRQOL profiles: high (20.3% of survivors), average (34.5%), low (33.1%), and very low (12.1%). Membership in the low or very low versus high HRQOL profile was associated with:,high school versus college/graduate [low OR 5 2.98 (1.29, 6.85); very low OR 5 4.51 (1.53, 13.33)]; not working [low OR 5 2.20 (1.41, 3.43); very low OR 5 4.32 (2.33, 8.00)]; lack of consistent companionship [low OR 5 3.67 (1.85, 7.25); very low OR 5 6.22 (2.78, 13.92)]; and history of: lung condition [low OR 5 2.42 (1.34, 4.36); very low OR 5 4.28 (2.09, 8.77)]; anxiety/depression [low OR 5 2.76 (1.71, 4.46); very low OR 5 8.86 (4.74, 16.56)]; sleep disturbance [low OR 5 2.97 (1.25, 7.06); very low OR 5 6.21 (2.40, 16.08)]; and chemotherapy [low OR 5 3.29 (2.13, 5.08); very low OR 5 7.34 (3.75, 14.37)]. Protective factors associated with reduced likelihood of low/very low HRQOL profile membership included higher: financial well-being [low OR 5 0.82 (0.74, 0.90); very low OR 5 0.78 (0.68, 0.89)] and spirituality [low OR 5 0.63 (0.56, 0.71); very low OR 5 0.53 (0.45, 0.62)]. Conclusion: About 45% of early-phase breast cancer survivors in the present sample experienced low or very low HRQOL; early identification and targeted interventions can be used to improve HRQOL over time.
AB - Background: We aimed to identify health-related quality of life (HRQOL) profiles among breast cancer survivors and factors associated with each profile. Methods: Breast cancer survivors diagnosed 6–13 months earlier completed surveys assessing sociodemographic, clinical, and HRQOL variables (NIH PROMIS short forms). Using latent profile analysis (LPA), we grouped survivors into HRQOL profiles of PROMIS scores based on model fit and clinical interpretability. We used multinomial logistic regression models to determine clinical, psychosocial, and demographic factors associated with each HRQOL profile. Results: Among 1,638 breast cancer survivors, we identified four HRQOL profiles: high (20.3% of survivors), average (34.5%), low (33.1%), and very low (12.1%). Membership in the low or very low versus high HRQOL profile was associated with:,high school versus college/graduate [low OR 5 2.98 (1.29, 6.85); very low OR 5 4.51 (1.53, 13.33)]; not working [low OR 5 2.20 (1.41, 3.43); very low OR 5 4.32 (2.33, 8.00)]; lack of consistent companionship [low OR 5 3.67 (1.85, 7.25); very low OR 5 6.22 (2.78, 13.92)]; and history of: lung condition [low OR 5 2.42 (1.34, 4.36); very low OR 5 4.28 (2.09, 8.77)]; anxiety/depression [low OR 5 2.76 (1.71, 4.46); very low OR 5 8.86 (4.74, 16.56)]; sleep disturbance [low OR 5 2.97 (1.25, 7.06); very low OR 5 6.21 (2.40, 16.08)]; and chemotherapy [low OR 5 3.29 (2.13, 5.08); very low OR 5 7.34 (3.75, 14.37)]. Protective factors associated with reduced likelihood of low/very low HRQOL profile membership included higher: financial well-being [low OR 5 0.82 (0.74, 0.90); very low OR 5 0.78 (0.68, 0.89)] and spirituality [low OR 5 0.63 (0.56, 0.71); very low OR 5 0.53 (0.45, 0.62)]. Conclusion: About 45% of early-phase breast cancer survivors in the present sample experienced low or very low HRQOL; early identification and targeted interventions can be used to improve HRQOL over time.
KW - breast cancer
KW - cancer survivors
KW - functional assessment
KW - health-related quality of life
KW - symptom assessment
UR - http://www.scopus.com/inward/record.url?scp=105015445622&partnerID=8YFLogxK
U2 - 10.1097/OR9.0000000000000183
DO - 10.1097/OR9.0000000000000183
M3 - Article
AN - SCOPUS:105015445622
SN - 2637-5974
VL - 7
JO - Journal of Psychosocial Oncology Research and Practice
JF - Journal of Psychosocial Oncology Research and Practice
IS - 3
ER -